OKYO Pharma (LON:OKYO) Shares Down 24.3% – What’s Next?

OKYO Pharma Limited (LON:OKYO) dropped 24.3% during trading on Thursday . The stock traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.40 ($0.02). Approximately 364,142 shares changed hands during mid-day trading, a decline of 16% from the average daily volume of 431,999 shares. The stock had previously closed at GBX 1.85 ($0.02).

OKYO Pharma Trading Down 24.3 %

The company has a debt-to-equity ratio of 1.65, a quick ratio of 2.65 and a current ratio of 0.83. The company has a 50-day simple moving average of GBX 1.40 and a 200 day simple moving average of GBX 1.40. The company has a market capitalization of £23.24 million, a P/E ratio of -140.00 and a beta of -0.06.

OKYO Pharma Company Profile

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain.